Disc Medicine (IRON) Total Liabilities (2020 - 2026)
Disc Medicine (IRON) reported Total Liabilities of $61.8 million for Q1 2026, up 26.34% year-over-year from $48.9 million in Q1 2025, and down 7.86% on a QoQ basis from $67.1 million in Q4 2025.
Disc Medicine (IRON) has 7 years of Total Liabilities data on file, last reported at $61.8 million in Q1 2026.
- Quarterly Total Liabilities rose 26.34% year-over-year to $61.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61.8 million (up 26.34% YoY) and the FY2025 annual result came in at $67.1 million, up 26.07% from the prior year.
- Total Liabilities fell to $61.8 million in Q1 2026 per IRON's latest filing, from $67.1 million in the prior quarter.
- Across five years, Total Liabilities topped out at $67.1 million in Q4 2025 and bottomed at $1.5 million in Q3 2022.
- The 5-year median for Total Liabilities is $22.9 million (2023), against an average of $30.1 million.
- The widest annual swing landed in 2022, when Total Liabilities sank 90.02%; it then surged 1096.93% in 2023.
- Tracing IRON's Total Liabilities over 5 years: stood at $23.6 million in 2022, then dropped by 3.09% to $22.9 million in 2023, then soared by 132.51% to $53.2 million in 2024, then gained by 26.07% to $67.1 million in 2025, then dropped by 7.86% to $61.8 million in 2026.
- Per Business Quant, the three latest IRON Total Liabilities figures stand at $61.8 million (Q1 2026), $67.1 million (Q4 2025), and $57.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - | 61.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.78 Mn |
| Dec 31, 2025 | 67.05 Mn |
| Sep 30, 2025 | 57.07 Mn |
| Jun 30, 2025 | 50.90 Mn |
| Mar 31, 2025 | 48.90 Mn |
| Dec 31, 2024 | 53.19 Mn |
| Sep 30, 2024 | 27.19 Mn |
| Jun 30, 2024 | 21.39 Mn |
| Mar 31, 2024 | 16.11 Mn |
| Dec 31, 2023 | 22.88 Mn |
| Sep 30, 2023 | 17.52 Mn |
| Jun 30, 2023 | 12.96 Mn |
| Mar 31, 2023 | 10.93 Mn |
| Dec 31, 2022 | 23.61 Mn |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 6.44 Mn |
| Mar 31, 2022 | 12.67 Mn |
| Dec 31, 2021 | 14.76 Mn |
| Sep 30, 2021 | 14.67 Mn |
| Jun 30, 2021 | 14.74 Mn |
| Mar 31, 2021 | 18.22 Mn |
| Dec 31, 2020 | 30.18 Mn |
| Sep 30, 2020 | 4.78 Mn |
| Jun 30, 2020 | 6.62 Mn |
| Mar 31, 2020 | -10,000.00 |